Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

A cross-sectional survey of measles preparedness in critical-access hospitals of Idaho.

Kanwar A, Heppler S, Donskey C, Brown CK.

Am J Infect Control. 2019 Dec 12. pii: S0196-6553(19)30981-2. doi: 10.1016/j.ajic.2019.11.015. [Epub ahead of print]

PMID:
31839277
2.

A call for improved occupational surveillance for measles in the United States.

Brown CK.

Am J Infect Control. 2019 Dec;47(12):1519-1520. doi: 10.1016/j.ajic.2019.06.012. Epub 2019 Jul 23. No abstract available.

PMID:
31345613
3.

Developing a Personal Protective Equipment Selection Matrix for Preventing Occupational Exposure to Ebola Virus.

Brown CK, Matthews DL, Thomas RJ, Edens AL.

Health Secur. 2019 May/Jun;17(3):213-228. doi: 10.1089/hs.2019.0014. Epub 2019 Jun 7.

PMID:
31173502
4.

Zika virus in workers: Considerations for ongoing exposure prevention.

Brown CK, Shugart JM.

Am J Ind Med. 2019 Jun;62(6):455-459. doi: 10.1002/ajim.22978. Epub 2019 Apr 26.

PMID:
31025402
5.

Respiratory Protection Against Emerging Infectious Diseases: Face Masks, Respirators, and Tools for Choosing Between Them.

Brown CK.

Health Secur. 2019 Mar/Apr;17(2):133-139. doi: 10.1089/hs.2018.0056. Epub 2019 Apr 9. Review.

PMID:
30964345
6.

FIP Guidelines for Dissolution Testing of Solid Oral Products.

Friedel HD, Brown CK, Barker AR, Buhse LF, Keitel S, Kraemer J, Morris JM, Reppas C, Sperry DC, Sakai-Kato K, Stickelmeyer MP, Shah VP.

J Pharm Sci. 2018 Dec;107(12):2995-3002. doi: 10.1016/j.xphs.2018.08.007. Epub 2018 Aug 25.

PMID:
30148985
7.

Impaired Latent Inhibition in GDNF-Deficient Mice Exposed to Chronic Stress.

Buhusi M, Brown CK, Buhusi CV.

Front Behav Neurosci. 2017 Oct 10;11:177. doi: 10.3389/fnbeh.2017.00177. eCollection 2017.

8.

Artificial neural networks: Predicting head CT findings in elderly patients presenting with minor head injury after a fall.

Dusenberry MW, Brown CK, Brewer KL.

Am J Emerg Med. 2017 Feb;35(2):260-267. doi: 10.1016/j.ajem.2016.10.065. Epub 2016 Nov 3.

PMID:
27876174
9.

The Effectiveness of Exercise on Recovery and Clinical Outcomes in Patients With Soft Tissue Injuries of the Hip, Thigh, or Knee: A Systematic Review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.

Brown CK, Southerst D, Côté P, Shearer HM, Randhawa K, Wong JJ, Yu H, Varatharajan S, Sutton D, Stern PJ, D'Angelo K, Dion S, Cox J, Goldgrub R, Stupar M, Carroll LJ, Taylor-Vaisey A.

J Manipulative Physiol Ther. 2016 Feb;39(2):110-120.e1. doi: 10.1016/j.jmpt.2016.01.003.

PMID:
26976374
10.

The effectiveness of manual therapy for the management of musculoskeletal disorders of the upper and lower extremities: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.

Southerst D, Yu H, Randhawa K, Côté P, D'Angelo K, Shearer HM, Wong JJ, Sutton D, Varatharajan S, Goldgrub R, Dion S, Cox J, Menta R, Brown CK, Stern PJ, Stupar M, Carroll LJ, Taylor-Vaisey A.

Chiropr Man Therap. 2015 Oct 27;23:30. doi: 10.1186/s12998-015-0075-6. eCollection 2015. Review.

11.

Guyon Canal Syndrome: lack of management in a case of unresolved handlebar palsy.

Brown CK, Stainsby B, Sovak G.

J Can Chiropr Assoc. 2014 Dec;58(4):413-20.

12.

The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.

Inglis DJ, Lavranos TC, Beaumont DM, Leske AF, Brown CK, Hall AJ, Kremmidiotis G.

Cancer Biol Ther. 2014;15(11):1552-60. doi: 10.4161/15384047.2014.956605.

13.

Biorelevant in vitro performance testing of orally administered dosage forms-workshop report.

Reppas C, Friedel HD, Barker AR, Buhse LF, Cecil TL, Keitel S, Kraemer J, Morris JM, Shah VP, Stickelmeyer MP, Yomota C, Brown CK.

Pharm Res. 2014 Jul;31(7):1867-76. doi: 10.1007/s11095-014-1348-9. Epub 2014 Mar 19.

PMID:
24643933
14.

Boryl-functionalized σ-alkynyl and vinylidene rhodium complexes: synthesis and electronic properties.

Braunschweig H, Brown CK, Dewhurst RD, Jimenez-Halla JO, Kramer T, Krummenacher I, Pfaffinger B.

Chemistry. 2014 Jan 27;20(5):1427-33. doi: 10.1002/chem.201303681. Epub 2013 Dec 20.

PMID:
24458915
15.

Voluntary STD testing and treatment program at a metropolitan correctional facility: evaluation of test acceptability and associated risk factors.

Brown CK, Earley M, Shaikh R, Fickenscher J, Ott J, Person A, Islam KM, Simonsen K, Sandkovsky U, Kaiser KL, Foxall M, Margalit R.

J Correct Health Care. 2014 Jan;20(1):70-80. doi: 10.1177/1078345813508748.

PMID:
24352406
16.

Diverse reactions of N-heterocyclic carbenes with an alkynylborane and isolation of a reactive zwitterionic borataallene.

Bertermann R, Braunschweig H, Brown CK, Damme A, Dewhurst RD, Hörl C, Kramer T, Krummenacher I, Pfaffinger B, Radacki K.

Chem Commun (Camb). 2014 Jan 4;50(1):97-9. doi: 10.1039/c3cc46947f. Epub 2013 Nov 4.

PMID:
24185233
17.

Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma.

Fruehauf J, Lutzky J, McDermott D, Brown CK, Meric JB, Rosbrook B, Shalinsky DR, Liau KF, Niethammer AG, Kim S, Rixe O.

Clin Cancer Res. 2011 Dec 1;17(23):7462-9. doi: 10.1158/1078-0432.CCR-11-0534. Epub 2011 Oct 5.

18.

Preferential accumulation within tumors and in vivo imaging by functionalized luminescent dendrimer lanthanide complexes.

Alcala MA, Shade CM, Uh H, Kwan SY, Bischof M, Thompson ZP, Gogick KA, Meier AR, Strein TG, Bartlett DL, Modzelewski RA, Lee YJ, Petoud S, Brown CK.

Biomaterials. 2011 Dec;32(35):9343-52. doi: 10.1016/j.biomaterials.2011.07.076. Epub 2011 Sep 16.

19.

FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.

Brown CK, Friedel HD, Barker AR, Buhse LF, Keitel S, Cecil TL, Kraemer J, Morris JM, Reppas C, Stickelmeyer MP, Yomota C, Shah VP.

AAPS PharmSciTech. 2011 Jun;12(2):782-94. doi: 10.1208/s12249-011-9634-x. Epub 2011 Jun 18. No abstract available.

20.

Differential habitat use and niche partitioning by Pseudomonas species in human homes.

Remold SK, Brown CK, Farris JE, Hundley TC, Perpich JA, Purdy ME.

Microb Ecol. 2011 Oct;62(3):505-17. doi: 10.1007/s00248-011-9844-5. Epub 2011 Apr 19.

PMID:
21503776
21.

Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.

Lin C, Donaldson SS, Meza JL, Anderson JR, Lyden ER, Brown CK, Morano K, Laurie F, Arndt CA, Enke CA, Breneman JC.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1764-70. doi: 10.1016/j.ijrobp.2011.01.036. Epub 2011 Apr 4.

22.

Can clinical prediction rules used in acute pediatric ankle and midfoot injuries be applied to an adult population?

Smith KR, Brown CK, Brewer KL.

Am J Emerg Med. 2011 May;29(4):441-5. doi: 10.1016/j.ajem.2011.02.001. Epub 2011 Mar 29.

PMID:
21450433
23.

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, Donegan TE, Mintz AH, Engh JA, Bartlett DL, Brown CK, Zeh H, Holtzman MP, Reinhart TA, Whiteside TL, Butterfield LH, Hamilton RL, Potter DM, Pollack IF, Salazar AM, Lieberman FS.

J Clin Oncol. 2011 Jan 20;29(3):330-6. doi: 10.1200/JCO.2010.30.7744. Epub 2010 Dec 13.

24.

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.

Ribas A, Camacho LH, Lee SM, Hersh EM, Brown CK, Richards JM, Rodriguez MJ, Prieto VG, Glaspy JA, Oseguera DK, Hernandez J, Villanueva A, Chmielowski B, Mitsky P, Bercovici N, Wasserman E, Landais D, Ross MI.

J Transl Med. 2010 Sep 27;8:89. doi: 10.1186/1479-5876-8-89.

25.

Toward successful postbooking diversion: what are the next steps?

Ryan S, Brown CK, Watanabe-Galloway S.

Psychiatr Serv. 2010 May;61(5):469-77. doi: 10.1176/appi.ps.61.5.469.

PMID:
20439367
26.

Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial.

Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K.

Am J Gastroenterol. 2010 Apr;105(4):890-6. doi: 10.1038/ajg.2010.53. Epub 2010 Feb 23.

27.

FIP position paper on qualification of paddle and basket dissolution apparatus.

Brown CK, Buhse L, Friedel HD, Keitel S, Kraemer J, Morris JM, Stickelmeyer M, Yomota C, Shah VP; International Pharmaceutical Federation.

AAPS PharmSciTech. 2009;10(3):924-7. doi: 10.1208/s12249-009-9291-5. Epub 2009 Jul 16.

28.
29.

A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.

Zeh HJ 3rd, Brown CK, Holtzman MP, Egorin MJ, Holleran JL, Potter DM, Bartlett DL.

Ann Surg Oncol. 2009 Feb;16(2):385-94. doi: 10.1245/s10434-008-0179-5. Epub 2008 Nov 25.

PMID:
19034580
30.

Effects of spatial transformation on regional brain volume estimates.

Allen JS, Bruss J, Mehta S, Grabowski T, Brown CK, Damasio H.

Neuroimage. 2008 Aug 15;42(2):535-47. doi: 10.1016/j.neuroimage.2008.05.047. Epub 2008 Jun 3.

31.

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.

Chalikonda S, Kivlen MH, O'Malley ME, Eric Dong XD, McCart JA, Gorry MC, Yin XY, Brown CK, Zeh HJ 3rd, Guo ZS, Bartlett DL.

Cancer Gene Ther. 2008 Feb;15(2):115-25. Epub 2007 Dec 14.

32.

Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.

Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2008 Mar;15(3):754-63. Epub 2007 Dec 12.

PMID:
18080166
33.

Partially folded bovine pancreatic trypsin inhibitor analogues attain fully native structures when co-crystallized with S195A rat trypsin.

Getun IV, Brown CK, Tulla-Puche J, Ohlendorf D, Woodward C, Barany G.

J Mol Biol. 2008 Jan 18;375(3):812-23. Epub 2007 Nov 6.

PMID:
18054043
34.

Practicing medicine as if people do matter.

Brown CK.

Complement Ther Clin Pract. 2007 Nov;13(4):215-6. Epub 2007 Aug 31. No abstract available.

PMID:
17950175
35.

Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation.

Rao SS, Seaton K, Miller MJ, Schulze K, Brown CK, Paulson J, Zimmerman B.

J Psychosom Res. 2007 Oct;63(4):441-9. Epub 2007 Aug 1.

PMID:
17905054
36.

Structure and biological activities of beta toxin from Staphylococcus aureus.

Huseby M, Shi K, Brown CK, Digre J, Mengistu F, Seo KS, Bohach GA, Schlievert PM, Ohlendorf DH, Earhart CA.

J Bacteriol. 2007 Dec;189(23):8719-26. Epub 2007 Sep 14.

37.

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.

Dong Xda E, Ito N, Lotze MT, Demarco RA, Popovic P, Shand SH, Watkins S, Winikoff S, Brown CK, Bartlett DL, Zeh HJ 3rd.

J Immunother. 2007 Sep;30(6):596-606.

PMID:
17667523
38.

Masquerader: high mobility group box-1 and cancer.

Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT.

Clin Cancer Res. 2007 May 15;13(10):2836-48. Review.

39.

Values-based care.

Brown CK.

Br J Gen Pract. 2007 Mar;57(536):243. No abstract available.

40.

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ 3rd.

J Immunol. 2006 Dec 15;177(12):8701-7.

41.

D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.

Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV.

Carcinogenesis. 2007 Jan;28(1):151-62. Epub 2006 Aug 18.

PMID:
16920735
42.

Structure of the streptococcal cell wall C5a peptidase.

Brown CK, Gu ZY, Matsuka YV, Purushothaman SS, Winter LA, Cleary PP, Olmsted SB, Ohlendorf DH, Earhart CA.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18391-6. Epub 2005 Dec 12.

43.

Structure of peptide sex pheromone receptor PrgX and PrgX/pheromone complexes and regulation of conjugation in Enterococcus faecalis.

Shi K, Brown CK, Gu ZY, Kozlowicz BK, Dunny GM, Ohlendorf DH, Earhart CA.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18596-601. Epub 2005 Dec 8.

44.

Roles of the equatorial tyrosyl iron ligand of protocatechuate 3,4-dioxygenase in catalysis.

Valley MP, Brown CK, Burk DL, Vetting MW, Ohlendorf DH, Lipscomb JD.

Biochemistry. 2005 Aug 23;44(33):11024-39.

PMID:
16101286
45.

Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region.

Allen JS, Bruss J, Brown CK, Damasio H.

Neurobiol Aging. 2005 Oct;26(9):1245-60; discussion 1279-82.

PMID:
16046030
46.

Managing the difficult airway: a survey of residency directors and a call for change.

Reeder TJ, Brown CK, Norris DL.

J Emerg Med. 2005 May;28(4):473-8.

PMID:
15837035
47.

Local and state collaboration for effective preparedness planning.

Bashir Z, Lafronza V, Fraser MR, Brown CK, Cope JR.

J Public Health Manag Pract. 2003 Sep-Oct;9(5):344-51.

PMID:
15503597
48.

Biophysical analyses of designed and selected mutants of protocatechuate 3,4-dioxygenase1.

Brown CK, Vetting MW, Earhart CA, Ohlendorf DH.

Annu Rev Microbiol. 2004;58:555-85. Review.

PMID:
15487948
49.

Glioblastoma cells block radiation-induced programmed cell death of endothelial cells.

Brown CK, Khodarev NN, Yu J, Moo-Young T, Labay E, Darga TE, Posner MC, Weichselbaum RR, Mauceri HJ.

FEBS Lett. 2004 May 7;565(1-3):167-70.

50.

Comments on analyzing refractive data.

Pandit RT, Brown CK, Farjo AA.

J Cataract Refract Surg. 2003 Oct;29(10):1852; author reply 1852. No abstract available.

PMID:
14604696

Supplemental Content

Loading ...
Support Center